Home » Topics » BioWorld Science

BioWorld Science
RSS

TRAF2 and NCK-interacting protein kinase inhibitors discovered at Silverback Therapeutics

May 14, 2019

NB-01 leads to statistically significant improvements in diabetic neuropathic pain

May 14, 2019

Novel biomarkers of clinical efficacy of bevacizumab in the treatment of gastric cancer

May 14, 2019

WuXi Biologics describes new bispecific antibodies against EGFR and PD-1

May 14, 2019

Updated data presented from phase Ib/II study of RG-6206 in boys with DMD

May 14, 2019

CAR fusion proteins targeting Strep-tagged peptides patented by Fred Hutchinson, TUM

May 14, 2019

Flavonoid promotes pleiotropic neuroprotective effects

May 14, 2019

IMVT-1401 demonstrates promising safety, PK and PD in healthy subjects

May 14, 2019

Long non-coding RNA CASC9 has an oncogenic role in breast cancer

May 14, 2019

Plasma kallikrein inhibitor VE-4840 shows preclinical potential for treating diabetic retinopathy

May 14, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.